We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
GSK plc | NYSE:GSK | NYSE | Depository Receipt |
Price Change | % Change | Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.70 | 1.61% | 44.15 | 44.33 | 43.96 | 44.13 | 2,944,392 | 21:05:55 |
1.
|
Details of PDMR/person closely associated with them
('PCA')
|
|||
a)
|
Name
|
Mr B
McNamara
|
||
b)
|
Position/status
|
CEO,
Consumer Healthcare
|
||
c)
|
Initial
notification/
amendment
|
Initial
notification
|
||
2.
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|||
a)
|
Name
|
GlaxoSmithKline
plc
|
||
b)
|
LEI
|
5493000HZTVUYLO1D793
|
||
3.
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transaction(s) has been
conducted
|
|||
a)
|
Description
of the financial instrument
|
American
Depositary Shares ('ADSs')
ISIN:
US37733W1053
|
||
b)
|
Nature
of the transaction
|
Acquisition
of Ordinary Shares following the re-investment of dividends paid to
shareholders on 13 April 2017 on shares held in the Deferred Annual
Bonus Plan Post-Tax - matching award.
|
||
c)
|
Price(s)
and
volume(s)
|
Price(s)
|
Volume(s)
|
|
$41.1461
|
28.716
|
|||
d)
|
Aggregated
information
Aggregated
volume Price
|
n/a
(single transaction)
|
||
e)
|
Date of
the transaction
|
2017-04-25
|
||
f)
|
Place
of the transaction
|
New
York Stock Exchange (XNYS)
|
|
GlaxoSmithKline plc
|
|
(Registrant)
|
|
|
Date: April
25, 2017
|
|
|
|
|
By: VICTORIA
WHYTE
|
|
|
|
Victoria Whyte
|
|
Authorised
Signatory for and on
|
|
behalf
of GlaxoSmithKline plc
|
1 Year GSK Chart |
1 Month GSK Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions